A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Syndax Pharmaceuticals Inc.’s current trading price is -41.96% away from its 52-week high, while its distance from the 52-week low is 3.12%. The stock’s price range for this time frame has been between $16.81 and $29.86. The trading volume of the company’s shares in the Healthcare reached around 0.77 million for the day, which was evidently lower than the average daily volume of 0.78 million over the last three months.
Syndax Pharmaceuticals Inc. (SNDX) currently has a stock price of $17.33. The stock saw a sharp increase in the last trading session, hitting a high of $17.42 after opening at $17.35. The lowest recorded price for the day was $16.995 before it closed at $17.01.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Syndax Pharmaceuticals Inc.’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $29.86 on 02/02/23, and the lowest price during that time was $16.81, recorded on 09/14/23.
How Financial Performance Impacts Market Capitalization
Syndax Pharmaceuticals Inc. (SNDX) has experienced a quarterly decline of -20.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.24B and boasts a workforce of 107 employees.
Decoding Analysts’ Ratings for Syndax Pharmaceuticals Inc.
As of right now, 7 analysts are rating Syndax Pharmaceuticals Inc. as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.21, with a change in price of -4.29. Similarly, Syndax Pharmaceuticals Inc. recorded 835,141 in trading volume during the last 100 days, posting a change of -19.95%.
How SNDX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SNDX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
SNDX Stock Stochastic Average
Syndax Pharmaceuticals Inc.’s raw stochastic average for the past 50 days is currently at 6.35%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 13.28%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 11.59% and 9.01%, respectively.
SNDX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a loss of -31.91%.However, over the last six months, we can see a stronger performance of -22.29%. Over the last 30 days, the price of SNDX has leaped by -6.02%. And in the last five days, it has fallen by -3.99%.
